3 ms·
http://journals.sagepub.com/doi/10.1345/aph.1M141 http://journals.sagepub.com/doi/10.1345/aph.1M141 If the therapeutically value of an excipient is that they c
by belorn 9y ago
http://journals.sagepub.com/doi/10.1345/aph.1M141 http://journals.sagepub.com/doi/10.1345/aph.1M141
If the therapeutically value of an excipient is that they change the absorption rate of the active ingredient, then that effects the bioequivalence of the drug. For example, comments in this thread refereed to different sized particles in inhalers which can have a direct effect on absorption rates.
If we disregard the therapeutic effect from the rate and extent that the "active ingredient or active moiety in pharmaceutical equivalents or pharmaceutical alternatives" reaches the site of drug action, what is left to change the therapeutic effect?
- kgwgk 9y agoThe point is that you don't need to show that the therapeutic effect is the same, you need to show that you expect the therapeutic effect to be the same. The trials required to prove the latter are orders of magnitude simpler, faster and less expensive.